摘要
目的 研究血管紧张素转换酶抑制剂(ACEI)对于阻塞性睡眠呼吸暂停低通气综合征(OSAHS)合并高血压患者睡眠呼吸障碍的干预效应.方法 63例经多导睡眠图证实的OSAHS患者被纳入本研究(男54例,女9例),平均年龄(53±12)岁,按照其病情和服药情况分为3组,OSAHS无高血压组(A组)21例,OSAHS合并高血压未服降压药组(B组)19例,OSAHS合并高血压服用ACEI类降压药组(C组)23例.比较三组患者睡眠呼吸暂停低通气指数(AHI),睡眠时最低血氧饱和度(LSaO2).结果 C组患者AHI明显低于B组[(21,32±3.53)次/h vs(38.99±2.51)次/h,P<0.05],LSaO2明显高于B组[(79.43士7.54)%vs(72.56±10.5)%,P<0.05];C组和A组AHI和LSaO2差异无统计学意义(P>0.05).结论 ACEI类降压药可能具有改善OSAHS合并高血压患者睡眠呼吸障碍的效应.
Objective To investigate the effects of angiotensin converting enzyme inhibitors (ACEI) on apnea and hypopnea in patients with obstructive sleep apnea-hypopnea syndrome(OSAHS)complicated by hypertension. Methods 63 subjects with OSAHS examined by polysomnography (PSG)were enrolled in this study (male 54, female 9), average age ( 53 ± 12 ) years. The subjects were divided into 3 groups, group A(pure OSAHS group, n = 21), group B(hypertension patients with OSAHS without antihypertensive treatment group, n = 19), group C(hypertension patients with OSAHS with ACEI group, n =23). All subjects underwent 8-hour PSG monitoring and their data were analyzed. The apnea-hypopnea index (AHI) and lowest SaO2 (LSaO2) were compared among the three groups. Results The AHI of group C were lower significantly than that of group B [(21. 32±3. 53) n/h vs (38. 99±2.51) n/h,P 〈0. 05], while LSaO2 of group C were higher significantly than that of group B [(79. 43±7. 54) % vs(72.56±10. 5) %, P 〈0.05]. There was no significant difference in AHI and LSaO2 between group A and group C. Conclusions ACEI may have improving effects on apnea and hypopnea in hypertension patients with OSAHS.
出处
《国际呼吸杂志》
2011年第7期503-506,共4页
International Journal of Respiration